Correlation of HOMA-IR and HbA1C with hematological parameters in patient with Diabetes mellitus Type II in Kirkuk city

  • Nimat Mohammed Ibrahim Al-Qalam university college
  • Nada Malko Smko Al-Qalam university college
  • Ismail Maulood Department of Biology, College of Science, Salahaddin University, Erbil, Iraq
Keywords: HbA1C, DM Type II , RBC,WBCs Platelet count

Abstract

Objective: The aim of this study was to investigate the relationship between hematological parameters and glycemic control in patients with type 2 diabetes mellitus (DM). Materials and Methods: This case-control study included 50 patients with DM and 50 healthy controls. Blood samples were collected from all participants to measure various hematological parameters and serum glucose, insulin, and HbA1c levels. Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) was calculated to evaluate insulin resistance. Statistical analysis was performed to compare the results between the groups and to determine the correlation between hematological parameters and glycemic control. Results: The results showed that serum glucose, insulin, HbA1c, serum potassium, RDW, platelet count, and MID were significantly increased in the DM group compared to the control group, while MCV was significantly decreased. The correlation analysis showed that MID, platelet count, PCT count, and PDW were positively correlated with serum glucose, HbA1c, and HOMA-IR, while MCV was negatively correlated with serum glucose and HbA1c. RBC count, RDW, and PCV were positively correlated with HbA1c and HOMA-IR.  Conclusions: The study found that DM type II patients had elevated serum glucose, insulin, HOMA IR, and HbA1C levels, as well as increased serum potassium and MID-range absolute count, and decreased MCV but increased RDW. Platelet count, PCT count, and PDW were positively correlated with serum glucose, HbA1C, and HOMA IR. These hematological parameters may serve as useful markers for assessing glycemic control and insulin resistance in DM type II patients.

References

American Diabetes Association. (2021). Standards of medical care in diabetes—2021. Diabetes Care, 44(Suppl 1), S1-S232. doi: 10.2337/dc21-S001.

Chehade, J. M., Gladysz, M., & Mooradian, A. D. (2013). Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs, 73(4), 327-339. doi: 10.1007/s40265-013-0023-3.

Colombo, M., Looker, H. C., Farran, B., et al. (2017). Serum concentrations of cholesterol, apolipoprotein A-I and apolipoprotein B in a total of 1694 meat-eaters, fish-eaters, vegetarians and vegans. European Journal of Clinical Nutrition, 71(4), 461-465. doi: 10.1038/ejcn.2016.175.

Dludla, P. V., Muller, C. J. F., Louw, J., Joubert, E., & Salie, R. (2017). Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos

American Diabetes Association. (2021). Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care, 44(Supplement 1), S15-S33. doi: 10.2337/dc21-S002

Bilir, B. E., Sarıkaya, R., Sarı, İ., & Yıldırım, S. (2021). The relationship between platelet indices and insulin resistance in patients with type 2 diabetes mellitus. Journal of Clinical and Analytical Medicine, 12(1), 48-51. doi: 10.4328/JCAM.7467

Balta, S., Demirkol, S., Celik, T., Iyisoy, A., & Kucuk, U. (2016). Red cell distribution width and platelet-to-lymphocyte ratio as potential predictors of early mortality in diabetic ketoacidosis. Journal of Investigative Medicine, 64(7), 1211-1216. doi: 10.1136/jim-2016-000051

Chehade, J. M., Gladysz, M., Mooradian, A. D., & Mathew, J. P. (2013). Hematological disorders in adult patients with diabetes mellitus. Journal of Diabetes and its Complications, 27(4), 294-301. doi: 10.1016/j.jdiacomp.2012.11.005

Dludla, P. V., Muller, C. J., & Louw, J. (2017). Potential beneficial effects of melatonin supplementation in diabetes and obesity. Current Drug Targets, 18(13), 1537-1544. doi: 10.2174/1389450117666161115100908

Fidan-Yaylalı, G., Kızıltunç, E., & Yaylalı, A. (2017). The role of red blood cell indices in the diagnosis of patients with diabetes mellitus. Journal of Clinical and Analytical Medicine, 8(3), 246-248. doi: 10.4328/JCAM.4818

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. doi: 10.1007/BF00280883

Patil, V. H., Patil, H. V., Shah, R., & Rupani, M. P. (2016). Red blood cell indices in type 2 diabetes mellitus. Journal of Diabetes and Metabolic Disorders, 15(1), 52. doi: 10.1186/s40200-016-0273-3

Wang, Y., Zhang, W., Jiang, W., & Chen, Y. (2020). Blood cell count and blood biochemical indexes of type 2 diabetes mellitus patients with different levels of glycated hemoglobin. Medicine, 99(12), e19361. doi: 10.1097/MD.0000000000019361

Yang, G., Zhu, Y., Dong, X., & Wu, J. (2019). Platelet indices in relation to insulin resistance in patients with newly diagnosed type 2 diabetes

Khan, R., Ali, K., Khan, M. W., Alam, K., & Khan, M. S. (2015). Importance of HbA1c test for diagnosis of diabetes mellitus and screening of pre-diabetes: a review. Journal of Diabetes Research, 2015, 1-11.

Soni, S., Badkul, R., & Bhatnagar, M. K. (2019). Mean platelet volume and platelet count as biomarkers in patients with diabetes mellitus. Journal of Medical Science and Clinical Research, 7(5), 366-370

Al-Rubeaan, K., Siddiqui, K., Al-Ghonaim, M., Youssef, A. M., Al-Sharqawi, A. H., & AlNaqeb, D. (2014). Elevated levels of fasting serum glucose, insulin, HbA1c and insulin resistance associated with the development of type 2 diabetes mellitus in Saudi women. Annals of Saudi Medicine, 34(5), 465–471. https://doi.org/10.5144/0256-4947.2014.465

American Diabetes Association. (2022). Standards of medical care in diabetes – 2022. Diabetes Care, 45(Supplement 1), S1–S255. https://doi.org/10.2337/dc22-SINT

Kahn, B. B., Flier, J. S., & Bar, R. S. (2006). The pathophysiology of insulin resistance and its relationship to metabolic disease. In J. E. Trosko & C. C. Chang (Eds.), Mechanisms of Environmental Carcinogenesis (Vol. 3, pp. 27–41). Springer. https://doi.org/10.1007/978-0-387-34751-6_2

Chen, Y., Zhang, X., Pan, B., Jin, X., Yao, H., Chen, B., Huang, Y., & Wu, Y. (2013). Serum potassium is positively associated with insulin resistance in patients with type 2 diabetes. Endocrine, 44(2), 404–409. https://doi.org/10.1007/s12020-013-9927-1

Singh, D. K., Singh, S., Singh, B., & Singh, A. K. (2021). Serum potassium levels in patients with uncontrolled diabetes mellitus: A cross-sectional study. Journal of Family Medicine and Primary Care, 10(1), 166–171. https://doi.org/10.4103/jfmpc.jfmpc_1349_19

Umpierrez, G. E., Kelly, J. P., Navarrete, J. E., Casals, M. M., Kitabchi, A. E., & Hyperglycemia Hispanic America Diabetes Outcome (HHADO) Study Group. (2002). Hyperglycemic crises in urban blacks. Archives of Internal Medicine, 162(19), 2235–2240. https://doi.org/10.1001/archinte.162.19.2235

Ogawa, S., Matsui, H., Kondo, Y., Nomura, M., Murakami, M., & Matsumoto, M. (2018). The pathophysiology of hyperkalemia in diabetes mellitus. Journal of Diabetes Investigation, 9(6), 1199–1204. https://doi.org/10.1111/jdi.12827

Hjelm, K., Dahlöf, P., Hansson, P.-O., & Johansson, B. (2014). Differences in laboratory test results between Swedish and US primary care settings: Lessons from a population-based study of type 2 diabetes mellitus. Scandinavian Journal of Primary Health Care, 32(3), 136–142. https://doi.org/10.3109/02813432.2014.941032

Singh, R., Barden, A., Mori, T., & Beilin, L. (2015). Advanced glycation end-products: A review. Diabetologia, 44(2), 129–146. https://doi.org/10.1007/s00125-001-0766-4

Li, X., Li, C., Liang, Z., Li, D., Wang, X., Li, S., & Chen, Y. (2015). Red blood cell distribution width: A potential biomarker for clinical outcomes in diabetic nephropathy. International Urology and Nephrology, 47(3), 503–508. https://doi.org/10.1007/s11255-014-0919-x

Ghosh, S., Mukherjee, S., & Chatterjee, U. (2011). Hematological profile of type 2 diabetic patients in Eastern India. Journal of Natural Science, Biology, and Medicine, 2(2), 184–188. https://doi.org/10.4103/0976-9668.92315

Korkmaz, M., Sahin, M., Aynioglu, O., Aksu, M., & Guzel, M. (2019). Predictive value of mid-range absolute monocyte count in type 2 diabetes mellitus. Medical Science Monitor, 25, 3286–3293. https://doi.org/10.12659/MSM.915566

Gomes, J. M., Costa, J. A., Alfenas, R. de C. G., & de Paula, S. O. (2014). Metabolic endotoxemia and diabetes mellitus: A systematic review. Metabolism, 63(2), 146–159. https://doi.org/10.1016/j.metabol.2013.10.002

Montecucco, F., Mach, F., & Schaller, K. (2013). Lymphocytes in atherosclerosis. European Journal of Clinical Investigation, 43(5), 539–542. https://doi.org/10.1111/eci.12085

Avogaro, A., Albiero, M., Menegazzo, L., de Kreutzenberg, S., & Fadini, G. P. (2012). Endothelial dysfunction in diabetes: The role of reparatory mechanisms. Diabetes Care, 35(4), 503–510. https://doi.org/10.2337/dc11-1724

De Luca, G., Venegoni, E., Iorio, S., & Secco, G. G. (2018). Mean platelet volume as a marker of platelet activation: Myth or reality in vascular medicine? Current Vascular Pharmacology, 16(2), 97–102. https://doi.org/10.2174/1570161115666180123114044

Falciglia, M., Freyberg, R. W., Almenoff, P. L., & D’Alessio, D. A. (2013). Elevated procalcitonin levels in patients with diabetes and the association with coronary artery disease. Journal of Clinical Endocrinology and Metabolism, 98(2), E290–E295. https://doi.org/10.1210/jc.2012-2502

Gasparyan, A. Y., Ayvazyan, L., & Mukanova, U. (2011). Platelets and diabetes mellitus. Current Pharmaceutical Design, 17(4), 378–384. https://doi.org/10.2174/138161211

Sakai, M., Matsumoto, K., Nishikawa, T., Suefuji, M., Nakamura, T., Inoue, H., & Inoue, K. (2015). Hematological parameters are associated with insulin resistance and atherosclerosis in patients with type 2 diabetes. Endocrine Journal, 62(11), 955-962.

Khorrami, A., Faraji, E., Oveisi, S., & Karimi, M. (2018). Hematocrit and risk of diabetes: A systematic review and meta-analysis. Acta Diabetologica, 55(11), 1105-1112.

Lippi, G., Targher, G., Montagnana, M., Salvagno, G. L., Zoppini, G., Guidi, G. C., & Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scandinavian Journal of Clinical and Laboratory Investigation, 68(3), 260-264

Wang, H., Wu, X., Zhang, G., Zhu, L., Xue, Y., Zhang, Z., & Zhang, H. (2020). Correlations between hematological parameters and insulin resistance in type 2 diabetes mellitus patients. Medicine, 99(11), e19403.

Yu, S., Lu, M., Ma, X., Xu, C., Wang, Y., Zhang, H., & Yang, W. (2021). Association of red blood cell distribution width with cardiovascular disease in patients with type 2 diabetes mellitus: A cross-sectional study. Journal of Diabetes

Published
2023-08-16
Section
Articles